Biostream

Company Overview

Snapshot

Founded in April 2025, Biostream operates with 1–10 employees. The company has secured funding across two rounds, including a grant from the Israel Innovation Authority in November 2025.

Business overview

Biostream is a Health Tech & Life Sciences company focused on Digital Healthcare, specifically Patient Remote Monitoring. The company develops a non-invasive, at-home urine testing system that leverages nano-sensors and AI to detect and monitor neurological biomarkers. Its core product combines a lateral flow assay with smartphone scanning and secure data transmission to a clinician-facing dashboard, facilitating ongoing monitoring and earlier intervention for conditions like hydrocephalus and normal pressure hydrocephalus (NPH). Biostream serves both B2B and B2C markets.

Company Intelligence Q&A

What is Biostream's primary focus?

Biostream focuses on developing a non-invasive, at-home urine testing system that utilizes nano-sensors and AI to detect and monitor neurological biomarkers for conditions such as hydrocephalus and normal pressure hydrocephalus (NPH).

When was Biostream founded?

Biostream was founded in April 2025.

What is the current product stage of Biostream's technology?

Biostream's technology is currently in the Beta stage. This stage indicates that the product is undergoing testing and refinement before a wider release.

Did Biostream receive any grants?

Yes, in November 2025, Biostream secured a grant from the Israel Innovation Authority.